Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SANTORO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.297
EU - Europa 580
AS - Asia 140
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 3.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.294
IT - Italia 266
CN - Cina 96
DE - Germania 72
FI - Finlandia 43
GB - Regno Unito 34
SE - Svezia 34
IE - Irlanda 28
RU - Federazione Russa 19
RO - Romania 18
UA - Ucraina 16
BE - Belgio 14
IN - India 10
IR - Iran 6
KR - Corea 6
NL - Olanda 6
CH - Svizzera 5
PK - Pakistan 5
RS - Serbia 5
ES - Italia 4
TR - Turchia 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
GR - Grecia 3
AT - Austria 2
BR - Brasile 2
CA - Canada 2
ET - Etiopia 2
FR - Francia 2
HR - Croazia 2
ID - Indonesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
EG - Egitto 1
IQ - Iraq 1
JP - Giappone 1
KW - Kuwait 1
LB - Libano 1
MX - Messico 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
VN - Vietnam 1
Totale 3.024
Salva come PNG Salva come JPEG
Città #
Fairfield 401
Chandler 272
Ashburn 260
Woodbridge 180
Wilmington 159
Houston 142
Cambridge 135
Seattle 132
Ann Arbor 89
Medford 54
Des Moines 45
Altamura 39
Princeton 36
Palermo 32
Lawrence 30
Dublin 28
New York 27
San Diego 24
Venice 21
Beijing 18
Boardman 15
Brussels 14
Nanjing 14
Helsinki 11
Milan 11
Biandronno 10
London 10
San Jose 10
Bremen 9
Rome 9
Ningbo 8
Ludwigshafen am Rhein 7
San Paolo di Civitate 7
Changsha 6
Jinan 6
Lentini 6
Nanchang 6
Guangzhou 5
Kumar 5
Tehran 5
Tianjin 5
Washington 5
Bari 4
Cagliari 4
Dearborn 4
Hebei 4
Kilburn 4
Rawalpindi 4
Redwood City 4
Shenyang 4
Bologna 3
Haikou 3
Hangzhou 3
Madrid 3
Pune 3
Zhengzhou 3
Aci Castello 2
Addis Ababa 2
Agrigento 2
Brno 2
Castelbuono 2
Chicago 2
Clearwater 2
Cumiana 2
Dhaka 2
Fuzhou 2
Groningen 2
Isola delle Femmine 2
Jakarta 2
Jiaxing 2
Kiev 2
Massa 2
Olgiate Olona 2
Orange 2
Phoenix 2
Redmond 2
Saint Paul 2
Saint Petersburg 2
Seongnam 2
Toronto 2
Tulsa 2
Warsaw 2
Zagreb 2
Altavilla Milicia 1
Ankara 1
Atlanta 1
Auburn Hills 1
Auckland 1
Brindisi 1
Casalecchio Di Reno 1
Catania 1
Charlotte 1
Cluj-napoca 1
Collegeville 1
Cosenza 1
Dallas 1
Derry 1
Dubai 1
Edinburgh 1
Esslingen am Neckar 1
Totale 2.429
Salva come PNG Salva come JPEG
Nome #
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 191
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 179
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 171
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 170
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 164
Immunosenescence and lymphomagenesis 142
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. 133
A Multicenter Real-Life Study On Anticoagulant Treatment With Direct Oral Anticoagulants In Patients With Ph Negative Myeloproliferative Neoplasms 130
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study 129
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 119
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis 105
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? 96
Cardiovascular risk factor in MPN patients 93
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 90
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. 88
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 88
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 84
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 83
Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms 82
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 77
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 75
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 60
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity 60
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 59
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 59
THE ANTINEOPLASTIC ROLE OF STAT5 INHIBITION IN BCRABL1-POSITIVE CELLS EXPOSED TO PIMOZIDE ALONE AND IN COMBINATION WITH DASATINIB AND PONATINIB 59
A case of severe dermatitis in a patient with Polycythemia Vera during cytoreductive therapy 55
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 50
Bone damage after chemotherapy for lymphoma: a real-world experience 50
Familial essential thrombocythemia: 6 cases from a mono‐institutional series 45
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review 38
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy 38
Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant 38
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma 38
Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents 36
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI) 34
Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy 21
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia 12
null 3
Totale 3.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019100 0 0 0 0 0 0 0 0 0 24 44 32
2019/2020571 29 6 20 72 32 71 77 39 73 54 70 28
2020/2021793 25 50 105 201 49 35 46 68 60 81 22 51
2021/2022551 40 60 18 53 13 42 24 31 56 92 48 74
2022/2023755 68 147 23 93 67 125 33 60 106 4 20 9
2023/2024290 15 46 22 78 21 57 31 14 0 6 0 0
Totale 3.244